Research Analyst Conduct

The research-analyst conduct rule is the single most consequential compliance regime governing how investment banking and the research department coexist inside the same firm. Every other internal-communications rule layers on top of this one.

What Is the Information Barrier Between Banking and Research?

Firms must establish, maintain, and enforce written policies and procedures reasonably designed to identify and effectively manage conflicts of interest between investment banking and research.

• Prohibited: Investment banking personnel cannot supervise or control research analysts
• Prohibited: Research analyst compensation may NOT be based on specific investment banking transactions or contributions to banking revenue
• Permissible compensation factors: Overall firm revenue, productivity of the analyst, and quality of research output
• An independent annual compensation committee reviews analyst pay, weighing the analyst's productivity, research quality, the correlation between the analyst's recommendations and how those securities performed, and independent ratings from clients, sales force, peers, and outside ratings services; investment banking personnel may not sit on that committee

The information barrier separates the private side (investment banking) from the public side (research, sales, trading, asset management). Bankers and analysts can work at the same firm, but reporting lines, compensation, and substantive collaboration on research output are walled off.

Exam Tip: Gotchas

• Research analyst compensation may NOT be tied to specific investment banking transactions. Pegging an analyst's bonus to whether the firm wins a healthcare initial public offering (IPO) mandate is a direct rule violation.
• Bankers cannot supervise analysts and analysts cannot report up to banking. The reporting line is structural, not a matter of day-to-day judgment.
• Investment banking may not sit on the analyst compensation committee. The committee has to be independent of the business line the rule is designed to wall off.

Which Firms Get the Limited-Investment-Banking Exemption?

A firm with only occasional underwriting business gets relief from most of the analyst-conflict provisions.

• The exemption reaches a member that, averaged over the prior three years, participated in 10 or fewer investment banking services transactions per year as manager or co-manager and earned $5 million or less in gross investment banking revenue from them.
• For this test, "investment banking services transactions" means underwriting of corporate debt and equity, not municipal securities.
• A qualifying firm is relieved from the analyst compensation-committee, budget, supervision, and prepublication-review provisions.
• The insulation duty still applies. Even an exempt firm must keep information barriers or other safeguards that insulate research analysts from investment-banking, sales, and trading pressure.

Exam Tip: Gotchas

• The exemption is a two-part test: 10 or fewer deals per year AND $5 million or less in gross banking revenue, both averaged over three years. Miss either half and the full rule applies.
• The exemption never lifts the insulation duty. A small firm still cannot let bankers pressure analysts; only the heavier supervision, budget, and committee machinery falls away.

What Communications Between Banking and Research Are Prohibited?

The rule lists specific banker-to-analyst and analyst-to-banker activities that are flatly off-limits.

• Investment banking may not direct research analysts to engage in sales or marketing efforts for an investment banking transaction
• Investment banking may not direct research analysts to participate in any communication with a current or prospective customer about an investment banking services transaction
• Research analysts may not participate in pitches and other solicitations of investment banking business
• Research analysts may not participate in road shows for an investment banking transaction
• Emerging growth company (EGC) exception: an analyst may attend a pitch meeting for an EGC's IPO alongside banking personnel, but may not solicit business or engage in other otherwise-prohibited conduct; road-show participation stays prohibited even for an EGC offering

Think of it this way: the research analyst is supposed to be the firm's independent voice to investors. If the analyst joins the pitch team to win mandates, the independence is gone before the deal is even announced. If the analyst rides the road show, the analyst is now a salesperson, not a researcher. The rule draws the line at "no participation in the deal-winning or deal-marketing chain."

Exam Tip: Gotchas

• Research analyst road-show participation is prohibited. This is a frequent exam fact. Bankers run the road show; analysts do not present, even for an EGC offering.
• Research analyst pitch participation is prohibited, with one narrow exception. The pitchbook can cite published research, and an analyst may sit in on an EGC IPO pitch meeting, but the analyst still cannot solicit the business.

When Do Quiet Periods Apply?

Research reports and public appearances by an analyst about an issuer are restricted for a defined period around an offering. The quiet period is the window when the firm's research voice goes silent on the issuer.

Booster shots and pre-arranged favorable coverage scheduled to publish immediately after the quiet period ends are also prohibited. The rule prevents firms from timing a favorable initiation or upgrade to coincide with the end of the silent window.

Three exceptions narrow the general rule:

• Offering exceptions: The IPO and secondary-offering quiet periods do not apply to emerging growth company (EGC) offerings or to certain covered investment fund offerings
• Significant news exception: A report or public appearance about significant news or a significant event concerning the issuer may proceed during the quiet period with advance authorization from legal or compliance
• Actively traded securities relief: Additional relief from the secondary-offering quiet period applies when the issuer's securities qualify as actively traded and the Securities Act research safe harbor is available

Exam Tip: Gotchas

• The IPO quiet period is 10 calendar days; the secondary offering quiet period is 3 calendar days. Memorize 10 / 3.
• The two quiet periods bind different groups. The IPO quiet period binds any member that participated as an underwriter or dealer, which is broader than manager or co-manager. The secondary-offering quiet period binds only managers and co-managers; a non-manager syndicate member can publish research on the issuer immediately after pricing a secondary offering.
• Booster shots are prohibited. A favorable report queued up to drop the day after the quiet period ends violates the rule even if the report itself is timed perfectly.
• EGC and certain covered-investment-fund offerings are exempt from the quiet period entirely. Do not assume every IPO triggers 10 calendar days of silence; check whether the issuer is an EGC first.

What Disclosures Must Research Reports Include?

Every research report must disclose specific information that lets the reader weigh conflicts before relying on the analysis.

• Conflicts of interest, including the analyst's or firm's ownership and any material conflicts
• Rating system definitions and the distribution of ratings across the firm's research universe (how many buys, holds, sells)
• Compensation received or to be received from the subject company for investment banking services
• Whether the firm acted as manager or co-manager of a public offering of the subject company's securities within the past 12 months

The 12-month look-back on manager / co-manager status is the most frequently tested disclosure. A research report on a company whose IPO the firm co-managed 9 months ago must disclose that fact; at 13 months out, the disclosure is no longer required.

Exam Tip: Gotchas

• The manager / co-manager disclosure has a 12-month look-back. Inside 12 months: disclosed. Outside 12 months: not required.
• Distribution-of-ratings disclosure is firm-wide, not industry-specific. The disclosure shows the firm's overall mix of buys, holds, and sells across coverage, so the reader can calibrate whether "buy" actually means buy at this firm.
• The rule doesn't prohibit ALL communication between banking and research. The line is influence over the recommendation, not no contact. Bankers can receive published research the same way any client does; they cannot pressure the substance of upcoming reports. The firm's written controls also have to protect research from banking pressure, prepublication review, and solicitation, not just supervision.

What Should You Check on Exam Day?

• Confirm whether an issuer qualifies as an emerging growth company before applying the standard IPO quiet period; EGC offerings are exempt.
• Distinguish the significant-news exception (requires advance legal/compliance authorization) from a routine booster shot (always prohibited).
• Check whether a scenario tests the 10-day IPO clock (binds any underwriter or dealer in the deal) or the 3-day secondary-offering clock (binds only managers and co-managers).
• Verify the 12-month look-back on manager/co-manager disclosure before marking a research-report disclosure question right or wrong.
• Remember the compensation committee for research analysts must be independent of investment banking.